Concert Pharmaceuticals Company Profile (NASDAQ:CNCE)

About Concert Pharmaceuticals

Concert Pharmaceuticals logoConcert Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of small molecule drugs. The Company operates through the development of pharmaceutical products on its own behalf or in collaboration with others segment. It has clinical candidates under development, including AVP-786, CTP-656, CTP-730 and JZP-386. The Company's deuterated chemical entity platform (DCE Platform) enables it to identify compounds for deuteration and to design, evaluate, develop and manufacture deuterated compounds. The Company is utilizing its DCE Platform to discover and develop product candidates for a range of indications. The Company's product candidate, CTP-656, is a next generation potentiator that the Company is initially developing for the treatment of cystic fibrosis in patients having gating mutations, including the G551D mutation. AVP-786 is a combination of a deuterated dextromethorphan analog and a low dose of quinidine.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: CNCE
  • CUSIP:
Key Metrics:
  • Previous Close: $10.47
  • 50 Day Moving Average: $11.38
  • 200 Day Moving Average: $12.48
  • 52-Week Range: $9.64 - $25.04
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -5.08
  • P/E Growth: 0.00
  • Market Cap: $232.72M
  • Outstanding Shares: 22,227,000
  • Beta: 1.43
Additional Links:
Companies Related to Concert Pharmaceuticals:

Analyst Ratings

Consensus Ratings for Concert Pharmaceuticals (NASDAQ:CNCE) (?)
Ratings Breakdown: 6 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $26.50 (153.10% upside)

Analysts' Ratings History for Concert Pharmaceuticals (NASDAQ:CNCE)
Show:
DateFirmActionRatingPrice TargetDetails
7/11/2016Brean CapitalReiterated RatingBuyView Rating Details
7/1/2016Stifel NicolausInitiated CoverageBuy$23.00View Rating Details
3/9/2016JPMorgan Chase & Co.Lower Price TargetMarket Outperform$28.00 -> $24.00View Rating Details
3/9/2016JMP SecuritiesLower Price TargetMarket Outperform$28.00 -> $24.00View Rating Details
1/26/2016AegisReiterated RatingBuyView Rating Details
10/8/2015Roth CapitalInitiated CoverageBuy$32.00View Rating Details
6/24/2015Ladenburg ThalmannBoost Price TargetBuy$24.00 -> $27.00View Rating Details
(Data available from 8/30/2014 forward)

Earnings

Earnings History for Concert Pharmaceuticals (NASDAQ:CNCE)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/3/2016        
8/9/2016Q2($0.63)($0.60)ViewN/AView Earnings Details
5/5/2016Q116($0.45)($0.63)$1.24 millionViewN/AView Earnings Details
3/1/2016Q415($0.05)$0.03$11.24 million$10.30 millionViewN/AView Earnings Details
11/5/2015Q315($0.41)($0.39)$4.50 million$1.70 millionViewListenView Earnings Details
8/5/2015Q215($0.46)$1.80$1.66 million$3.25 millionViewListenView Earnings Details
5/8/2015Q115($0.38)($0.48)$2.70 million$1.30 millionViewListenView Earnings Details
2/27/2015Q414($0.60)($0.48)$1.38 millionViewN/AView Earnings Details
11/12/2014Q314($0.49)($0.43)$1.67 million$4.40 millionViewN/AView Earnings Details
8/12/2014Q214($0.42)($0.45)$1.30 million$1.20 millionViewN/AView Earnings Details
5/14/2014Q114($0.49)($0.76)$0.44 million$1.61 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Concert Pharmaceuticals (NASDAQ:CNCE)
Current Year EPS Consensus Estimate: $-2.51 EPS
Next Year EPS Consensus Estimate: $-2.06 EPS

Dividends

Dividend History for Concert Pharmaceuticals (NASDAQ:CNCE)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Concert Pharmaceuticals (NASDAQ:CNCE)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/12/2016Thomas G AuchinclossDirectorBuy2,000$10.11$20,220.00View SEC Filing  
5/11/2016Roger D TungCEOBuy19,610$10.55$206,885.50View SEC Filing  
12/16/2015Wilfred E JaegerDirectorSell10,360$19.57$202,745.20View SEC Filing  
12/15/2015Wilfred E JaegerDirectorSell54,572$20.10$1,096,897.20View SEC Filing  
12/14/2015Pauline McgowanVPSell498$20.07$9,994.86View SEC Filing  
12/14/2015Wilfred E JaegerDirectorSell3,922$20.09$78,792.98View SEC Filing  
11/9/2015Ronald W. BarrettDirectorSell17,699$22.27$394,156.73View SEC Filing  
11/2/2015Nancy StuartCOOSell23,216$24.29$563,916.64View SEC Filing  
9/18/2015Robert SilvermanVPSell10,000$20.00$200,000.00View SEC Filing  
9/10/2015Wilfred E JaegerDirectorSell120,000$18.22$2,186,400.00View SEC Filing  
8/18/2015Wilfred E JaegerDirectorSell760,000$15.81$12,015,600.00View SEC Filing  
8/13/2015Wilfred E JaegerDirectorSell92,215$16.75$1,544,601.25View SEC Filing  
8/12/2015Wilfred E JaegerDirectorSell97,785$17.49$1,710,259.65View SEC Filing  
6/8/2015Robert SilvermanVPSell5,000$16.35$81,750.00View SEC Filing  
3/11/2015Nancy StuartCOOSell46,430$15.00$696,450.00View SEC Filing  
3/11/2015Pauline McgowanVPSell5,973$16.00$95,568.00View SEC Filing  
3/10/2015Pauline McgowanVPSell22,122$13.90$307,495.80View SEC Filing  
11/18/2014Three Arch Management Iv, L.L.DirectorSell250,000$12.29$3,072,500.00View SEC Filing  
2/20/2014Skyline Venture Partners QualiMajor ShareholderBuy150,000$14.00$2,100,000.00View SEC Filing  
2/19/2014Life Science Ventures Vi G TvmDirectorBuy89,000$14.00$1,246,000.00View SEC Filing  
2/19/2014Plc GlaxosmithklineMajor ShareholderBuy35,000$14.00$490,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Concert Pharmaceuticals (NASDAQ:CNCE)
DateHeadline
capitalcube.com logoETF’s with exposure to Concert Pharmaceuticals, Inc. : August 29, 2016 (NASDAQ:CNCE)
www.capitalcube.com - August 29 at 4:30 PM
live-pr.com logoConcert Pharmaceuticals, Inc. (CNCE) - Financial and Strategic SWOT Analysis Review - New Report Available (NASDAQ:CNCE)
www.live-pr.com - August 26 at 4:15 PM
investornewswire.com logoWill Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) Surprise This Quarter? - Investor Newswire (NASDAQ:CNCE)
www.investornewswire.com - August 25 at 4:21 PM
finance.yahoo.com logoCONCERT PHARMACEUTICALS, INC. Financials (NASDAQ:CNCE)
finance.yahoo.com - August 18 at 4:19 PM
capitalcube.com logoConcert Pharmaceuticals, Inc. :CNCE-US: Earnings Analysis: Q2, 2016 By the Numbers : August 11, 2016 (NASDAQ:CNCE)
www.capitalcube.com - August 11 at 4:25 PM
News IconConcert Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Company Update (NASDAQ:CNCE)
www.digitaljournal.com - August 9 at 11:14 AM
sg.finance.yahoo.com logoConcert reports 2Q loss (NASDAQ:CNCE)
sg.finance.yahoo.com - August 9 at 11:14 AM
biz.yahoo.com logoCONCERT PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition (NASDAQ:CNCE)
biz.yahoo.com - August 9 at 11:14 AM
benzinga.com logoConcert Pharmaceuticals to Report Second Quarter... (NASDAQ:CNCE)
www.benzinga.com - August 2 at 9:05 AM
publicnow.com logoConcert Pharmaceuticals to Report Second Quarter 2016 Financial Results on August 9, 2016 (NASDAQ:CNCE)
www.publicnow.com - August 2 at 9:05 AM
News IconConcert Pharmaceuticals, Inc. (NASDAQ:CNCE): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NASDAQ:CNCE)
www.engelwooddaily.com - July 22 at 11:35 AM
News IconEarnings Focus and Crowd Sourced Sentiment Review for Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) - TGP (NASDAQ:CNCE)
telanaganapress.com - July 20 at 11:39 PM
News IconHeightened Volatility Spotted on Shares of: Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) - Engelwood Daily (NASDAQ:CNCE)
www.engelwooddaily.com - July 20 at 11:39 PM
News IconBvf INC Increased Concert Pharmaceuticals INC (NASDAQ:CNCE) by $6.80 Million as Shares Declined - Consumer Eagle (NASDAQ:CNCE)
www.consumereagle.com - July 17 at 8:55 AM
News IconShares Moving Down on the Week: Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) - Engelwood Daily (NASDAQ:CNCE)
www.engelwooddaily.com - July 17 at 8:55 AM
News IconHow Analysts Rated Concert Pharmaceuticals Inc (NASDAQ:CNCE) Last Week? - Consumer Eagle (NASDAQ:CNCE)
www.consumereagle.com - July 16 at 4:14 PM
News IconShares Experiencing a Downtrend: Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) - TGP (NASDAQ:CNCE)
telanaganapress.com - July 16 at 6:58 AM
News IconConcert Pharmaceuticals Inc's Stock Is Sell After Today's Huge Decline - Press Telegraph (NASDAQ:CNCE)
presstelegraph.com - July 15 at 10:59 AM
ftsenews.co.uk logoNew Broker Ratings For Concert Pharmaceuticals Inc (CNCE) - FTSE News (NASDAQ:CNCE)
www.ftsenews.co.uk - July 15 at 10:59 AM
News IconConcert Pharmaceuticals, Inc. (NASDAQ:CNCE) Earnings Concentration and Analyst Target Watch - Engelwood Daily (NASDAQ:CNCE)
www.engelwooddaily.com - July 15 at 10:59 AM
News IconConcert Pharmaceuticals Incorporated (NASDAQ:CNCE) Shorted Shares Decreased By 11.37% - Press Telegraph (NASDAQ:CNCE)
presstelegraph.com - July 14 at 9:50 PM
News IconInsiders Increasing Positions in: Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) - Press Telegraph (NASDAQ:CNCE)
presstelegraph.com - July 13 at 9:40 PM
News IconConcert Pharmaceuticals, Inc. (NASDAQ:CNCE) Wall Street Analyst Recommendation Outlook - Telanagana Press (NASDAQ:CNCE)
telanaganapress.com - July 13 at 12:23 PM
News IconCONCERT PHARMACEUTICALS (NASDAQ:CNCE) Institutional Investors Sentiment - Consumer Eagle (NASDAQ:CNCE)
www.consumereagle.com - July 13 at 12:23 PM
fiscalstandard.com logoBroker Outlook For Concert Pharmaceuticals Inc (CNCE) - Fiscal Standard (NASDAQ:CNCE)
www.fiscalstandard.com - July 13 at 12:23 PM
investornewswire.com logoWill Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) Surprise Analysts? - Investor Newswire (NASDAQ:CNCE)
www.investornewswire.com - July 12 at 8:33 AM
News IconConcert Pharmaceuticals Incorporated (NASDAQ:CNCE) Shorts Decreased by 11.37% After Short Covering - Engelwood Daily (NASDAQ:CNCE)
www.engelwooddaily.com - July 10 at 8:54 AM
fiscalstandard.com logoConcert Pharmaceuticals Inc (CNCE) Broker Price Targets For The Coming Week - Fiscal Standard (NASDAQ:CNCE)
www.fiscalstandard.com - July 10 at 8:54 AM
News IconBvf INC Increased Concert Pharmaceuticals INC (NASDAQ:CNCE) by $6.80 Million as Shares Declined - Press Telegraph (NASDAQ:CNCE)
presstelegraph.com - July 9 at 6:46 AM
News IconCompany Stock Focus for Concert Pharmaceuticals, Inc. (NASDAQ:CNCE): Which Way Will Shares Head? - Press Telegraph (NASDAQ:CNCE)
presstelegraph.com - July 8 at 11:58 AM
finance.yahoo.com logoConcert Pharmaceuticals Announces Webcast at Cantor Fitzgerald Healthcare Conference - Yahoo Finance (NASDAQ:CNCE)
finance.yahoo.com - July 7 at 4:18 PM
News IconStock Tracking Down This Month; Investor Alert on Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) - Engelwood Daily (NASDAQ:CNCE)
www.engelwooddaily.com - July 7 at 11:48 AM
publicnow.com logoConcert Pharmaceuticals Announces Webcast at Cantor Fitzgerald Healthcare Conference (NASDAQ:CNCE)
www.publicnow.com - July 6 at 7:11 AM
News IconCould Concert Pharmaceuticals Inc Decrease Even More? The Stock Formed Bearish Wedge Down Chart Pattern - Engelwood Daily (NASDAQ:CNCE)
www.engelwooddaily.com - July 4 at 9:09 AM
finance.yahoo.com logoCoverage initiated on Concert Pharmaceuticals by Stifel (NASDAQ:CNCE)
finance.yahoo.com - July 1 at 7:00 AM
News IconConcert Pharmaceuticals, Inc. (NASDAQ:CNCE) Company Rating and Target Watch - Telanagana Press (NASDAQ:CNCE)
telanaganapress.com - June 30 at 9:44 PM
News IconShare Update and Earnings Review for Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) - Press Telegraph (NASDAQ:CNCE)
presstelegraph.com - June 28 at 4:17 PM
seekingalpha.com logoA Look At Concert Pharmaceuticals - Seeking Alpha (NASDAQ:CNCE)
seekingalpha.com - June 28 at 4:17 PM
News IconConcert Pharmaceuticals, Inc. (NASDAQ:CNCE) Earnings Glance and Target Price Review - Engelwood Daily (NASDAQ:CNCE)
www.engelwooddaily.com - June 24 at 4:25 PM
ftsenews.co.uk logoConcert Pharmaceuticals Inc (CNCE) Updated Price Targets - FTSE News (NASDAQ:CNCE)
www.ftsenews.co.uk - June 24 at 8:02 AM
News IconCovering the Bases on Concert Pharmaceuticals, Inc. (NASDAQ:CNCE): Where is the Stock Going? - Press Telegraph (NASDAQ:CNCE)
presstelegraph.com - June 24 at 8:02 AM
fiscalstandard.com logoConcert Pharmaceuticals Inc (CNCE) Current Analyst Ratings - Fiscal Standard (NASDAQ:CNCE)
www.fiscalstandard.com - June 22 at 4:27 PM
biz.yahoo.com logoCONCERT PHARMACEUTICALS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders (NASDAQ:CNCE)
biz.yahoo.com - June 10 at 4:13 PM
streetinsider.com logoConcert Pharma (CNCE) Announces Results from CTP-656 Phase 1 in CF; Superior PK Profile Noted - StreetInsider.com (NASDAQ:CNCE)
www.streetinsider.com - June 10 at 12:21 PM
publicnow.com logoConcert Pharmaceuticals Presents CTP-656 Phase 1 Results at European Cystic Fibrosis Conference (NASDAQ:CNCE)
www.publicnow.com - June 10 at 10:49 AM
news.cmlviz.com logoCONCERT PHARMACEUTICALS INC. (NASDAQ:CNCE) Financial Condition Compared to S&P 500 - CML News (NASDAQ:CNCE)
news.cmlviz.com - June 8 at 12:52 PM
News IconConcert Pharmaceuticals Incorporated (NASDAQ:CNCE) Shorts Decreased by 12.56% After Short Covering - HNN (NASDAQ:CNCE)
hintsnewsnetwork.com - June 6 at 7:43 AM
News IconConcert Pharmaceuticals Inc (CNCE) Broker Price Targets For The Coming Week - Share Trading News (NASDAQ:CNCE)
www.sharetrading.news - June 5 at 12:06 PM
cchdailynews.com logoBvf INC Increased Concert Pharmaceuticals INC (NASDAQ:CNCE) by $6.80 Million as Shares Declined - CCH Daily News (NASDAQ:CNCE)
cchdailynews.com - June 3 at 10:26 PM
News IconConcert Pharmaceuticals, Inc. (NASDAQ:CNCE) Stock Update & Estimates - Stock Tick Tock (NASDAQ:CNCE)
www.stockticktock.com - June 3 at 4:27 PM

Social

Concert Pharmaceuticals (NASDAQ:CNCE) Chart for Tuesday, August, 30, 2016


Last Updated on 8/30/2016 by MarketBeat.com Staff